Overall verdict
Buy
6.5/10
1-year performance
-31.47%
Score breakdown
Down 31.5% over 1 year, 1% of the 52-week range.
Strongest: Financial strength 10.0/10. Weakest: Profitability 4.3/10.
6 analysts, target +0.6% vs the price.
RLX Technology Inc., through its subsidiaries, develops, manufactures, and sells e-vapor products in the People's Republic of China and internationally. It offers rechargeable e-vapor products under the Qingyu, Phantom, Phantom Pro, Zeus, Leili, and Daqian names; and disposable e-vapor products under the Feiliu and Feiliu Mega names. The company also provides closed-system rechargeable products, open-system products, closed-system disposable products, and modern oral products.
It sells its products through local channels, third-party distribution channels, and distribution channels co-managed with third parties, as well as online and offline end users. The company was founded in 2018 and is headquartered in Shenzhen, the People's Republic of China.
Sector
Consumer Staples
Industry
Tobacco
Primary listing
Nyse
China
CEO
Ms. Wang Ying
Founded
2018
Employees
897
Revenue / employee
4.0M CNY
Next earnings
November 13, 2026 (estimated)
Institutional holders
- First Beijing Investment Ltd4.79%
- IDG China Venture Capital Fund V Associates L.P.4.41%
- NOMURA HOLDINGS INC1.81%
- VANGUARD CAPITAL MANAGEMENT LLC1.68%
- OLP CAPITAL MANAGEMENT Ltd1.07%
- BlackRock, Inc.0.77%
- D. E. Shaw & Co., Inc.0.77%
- Aspex Management (HK) Ltd0.63%
- Perseverance Asset Management International0.59%
- Other institutions4.71%
- Rest of the register78.77%
105 13F filings as of June 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
2.68 USD
52-week low
1.67 USD
1-year performance
-31.47%
Declining
Year-to-date performance
-26.50%
Declining
Drawdown
-37.13%
Major drawdown
Position in the 52-week range
1% of range
Range: 2.54 USD - 2.70 USD (2 methods agree)
Gross margin 35.0%, net margin 21.9%, ROIC 6.2%, ROE 6.2%.
Net margin
21.87%
Exceptional
Sector 8.87%|S&P 12.97%
Gross margin
34.97%
Fair
Return on equity (ROE)
6.20%
Low
Sector 13.33%|S&P 16.52%
Return on invested capital (ROIC)
6.19%
Fair
Free cash flow margin (FCF)
—
Margin stability
7.4 pts
Uneven
Revenue to net income
Growth
4.6/10Revenue up 22.7% over 1 year, -1.9% a year over 5.
Revenue (trailing 12 months)
4.6Md CNY
Revenue growth (1y)
22.69%
Solid
Revenue growth (3y)
-35.83%
Declining
EPS growth (1y)
6.99%
Moderate
EPS CAGR (5y)
—
EPS revisions (3 months)
-7.87%
Sharply revised down
Valuation
8.5/10P/E 14.4x, forward P/E 12.9x, PEG 0.38.
P/E (TTM)
14.4x
Fair
Sector 14.5x|S&P 23.0x
Forward P/E
12.9x
Fair
EV / EBITDA
—
Sector 9.6x|S&P 14.5x
PEG
0.38
Growth unpriced
Sector 0.02|S&P 0.86
Fair value (reverse DCF)
2.62 USD
Deeply undervalued
Market cap
14.1Md CNY
Financial strength
10.0/10Cash covers 3675.5% of the debt, net debt/EBITDA -24.2x.
Net debt / EBITDA
-24.2x
Net cash
Gearing (net debt / equity)
-55.84%
Net cash
Cash
9.5Md CNY
Cash / market cap
67.26%
Very solid
Cash / total debt
3675.50%
Net cash
Interest coverage
51.4x
Very solid
Net debt
-9.2Md CNY
Equity
16.5Md CNY
Closed daily candles, 2 years
Last close on September 24, 2026: 1.71 USD
- MM201.76
- MM501.88
- MM2002.11
- RSI 1437.9
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
-3.18%
200-day average slope, 3 months
-7.81%
50-day average slope, 1 month
-3.27%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
1.61 % per day
Volatility change
-15.41%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 0.88 (1) | 0.90 (5) | 5 892 (6) | 883 (4) | 1 078 (1) |
| 2027 | 0.98 (2) | 1.09 (6) | 7 302 (6) | 1 153 (4) | 1 176 (3) |
Amounts in millions of CNY, EPS in CNY per share. In brackets, the number of analysts. Consensus as of August 24, 2026.
Same sub-industry: 20 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2914 | 6.7 | 6.4 | 77.2Md USD | 19.6x | 16.4 % | 20.0 % | 10.7 % | 0.9x | 4.3 % | 43.9 % | ||
| 2 | A033780 | 6.5 | 5.1 | 13.2Md USD | 12.7x | 20.6 % | 9.9 % | 13.5 % | 0.3x | 2.4 % | 21.2 % | ||
| 3 | RLX | 6.5 | 6.5 | 2.1Md USD | 14.4x | 21.9 % | 22.7 % | 6.2 % | -24.2x | — | -31.5 % | ||
| 4 | MO | 6.0 | 5.9 | 115Md USD | 14.5x | 38.9 % | 1.2 % | 39.2 % | 1.4x | 7.9 % | 6.4 % | ||
| 5 | PM | 5.7 | 4.3 | 297Md USD | 27.4x | 25.5 % | 10.2 % | 33.8 % | 2.3x | 4.3 % | 17.1 % | ||
| 6 | ITC | 5.5 | 5.9 | 35.3Md USD | 17.0x | 25.9 % | -11.1 % | — | -0.8x | — | -33.3 % | ||
| 7 | IMB | 5.4 | 6.4 | 24.6Md USD | 11.7x | 9.0 % | 2.7 % | 13.4 % | 1.9x | 15.1 % | -20.1 % | ||
| 8 | BATS | 4.7 | 4.5 | 120Md USD | 14.7x | 24.6 % | -1.0 % | 8.0 % | 2.5x | 6.0 % | 7.8 % | ||
| 9 | 6969 | 4.0 | 2.6 | 7.3Md USD | 45.0x | 7.4 % | 20.9 % | 5.2 % | -6.4x | 0.9 % | -47.3 % |
